Established in May 2020, Shenzhen Hailife Biotechnology has gathered a group of high-quality talents led by doctors in molecular biology. Motivated by innovation and creation, Hailife is dedicated to bringing high quality IVD solutions closer to primary health care institutions which could greatly shorten the waiting time for treatment, better manage chronic disease, quickly answer acute infection.